MX2012004055A - Metodo para la preparacion de ester (r) -1-aril-2-tetrazolil-etili co de acido carbamico. - Google Patents
Metodo para la preparacion de ester (r) -1-aril-2-tetrazolil-etili co de acido carbamico.Info
- Publication number
- MX2012004055A MX2012004055A MX2012004055A MX2012004055A MX2012004055A MX 2012004055 A MX2012004055 A MX 2012004055A MX 2012004055 A MX2012004055 A MX 2012004055A MX 2012004055 A MX2012004055 A MX 2012004055A MX 2012004055 A MX2012004055 A MX 2012004055A
- Authority
- MX
- Mexico
- Prior art keywords
- tetrazolyl
- aryl
- preparation
- carbamic acid
- thyl ester
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se divulga un método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico, que comprende la reducción de enzima enantioselectiva de la arilcetona correspondiente y la carbamatación del alcohol resultante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25186709P | 2009-10-15 | 2009-10-15 | |
PCT/KR2010/007069 WO2011046380A2 (en) | 2009-10-15 | 2010-10-15 | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012004055A true MX2012004055A (es) | 2012-08-31 |
Family
ID=43876717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012004055A MX2012004055A (es) | 2009-10-15 | 2010-10-15 | Metodo para la preparacion de ester (r) -1-aril-2-tetrazolil-etili co de acido carbamico. |
Country Status (19)
Country | Link |
---|---|
US (3) | US8404461B2 (es) |
EP (1) | EP2488505B1 (es) |
JP (1) | JP5797656B2 (es) |
KR (1) | KR101708437B1 (es) |
CN (1) | CN102574821B (es) |
AU (1) | AU2010307466B2 (es) |
BR (1) | BR112012008858B1 (es) |
CA (1) | CA2776743C (es) |
CL (1) | CL2012000959A1 (es) |
ES (1) | ES2536488T3 (es) |
HK (1) | HK1172625A1 (es) |
HU (1) | HUE025816T2 (es) |
IL (1) | IL218787A0 (es) |
MX (1) | MX2012004055A (es) |
MY (1) | MY162997A (es) |
PL (1) | PL2488505T3 (es) |
RU (1) | RU2539983C2 (es) |
WO (1) | WO2011046380A2 (es) |
ZA (1) | ZA201202629B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI1013559A2 (pt) | 2009-03-23 | 2016-04-12 | Glenmark Pharmaceuticals Sa | compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos |
US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
CN103694187A (zh) * | 2014-01-06 | 2014-04-02 | 四川大学 | 5-氨基-1-苯甲酰氨基四唑及其金属配合物 |
KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
KR102421006B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도 |
KR102421013B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
BR112019012000A2 (pt) | 2016-12-14 | 2019-10-29 | Sk Biopharmaceuticals Co Ltd | medicamento e composição farmacêutica para prevenção, alívio ou tratamento de tremor ou síndrome do tremor, método para prevenir, aliviar ou tratar tremor ou síndrome do tremor, e, uso de um composto de carbamato |
US12070447B2 (en) | 2016-12-14 | 2024-08-27 | Sk Biopharmaceuticals Co., Ltd. | Parenteral liquid preparation comprising carbamate compound |
WO2018111002A1 (ko) | 2016-12-14 | 2018-06-21 | 에스케이바이오팜 주식회사 | 카바메이트 화합물을 포함하는 구강 붕해 정제 |
US10905675B2 (en) | 2016-12-14 | 2021-02-02 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for prevention, alleviation or treatment of pruritus |
WO2018111006A1 (ko) | 2016-12-14 | 2018-06-21 | 에스케이바이오팜 주식회사 | 탈수초성 질환의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
MX2019006940A (es) | 2016-12-14 | 2019-09-06 | Sk Biopharmaceuticals Co Ltd | Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar. |
KR20200074157A (ko) | 2017-11-14 | 2020-06-24 | 에스케이바이오팜 주식회사 | 카바메이트 화합물을 포함하는 조현병의 예방, 경감 또는 치료용 배합물 |
CN111432812A (zh) | 2017-11-14 | 2020-07-17 | 爱思开生物制药株式会社 | 用于预防、减轻或治疗失神发作或显示失神发作的癫痫的氨基甲酸酯化合物的用途 |
WO2019098632A1 (ko) | 2017-11-14 | 2019-05-23 | 에스케이바이오팜 주식회사 | 근긴장증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
EP3711757A4 (en) | 2017-11-14 | 2021-11-24 | SK Biopharmaceuticals Co., Ltd. | USE OF A CARBAMATE COMPOUND TO PREVENT, RELIEVE OR TREAT VISCERALGIA OR PAIN CAUSED BY VISCERAL DISEASE |
JP7258902B2 (ja) | 2017-11-14 | 2023-04-17 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 脆弱x症候群、アンジェルマン症候群又はレット症候群を含む発達障害の軽減又は治療のためのカルバメート化合物の使用 |
KR20200074152A (ko) | 2017-11-14 | 2020-06-24 | 에스케이바이오팜 주식회사 | 후기 나트륨 전류의 증가와 관련된 질환을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
JP7417595B2 (ja) | 2018-09-21 | 2024-01-18 | エスケー バイオファーマスティカルズ カンパニー リミテッド | てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用 |
BR112021005193A2 (pt) | 2018-09-21 | 2021-06-08 | Sk Biopharmaceuticals Co., Ltd. | medicamento e combinação para a prevenção, alívio ou tratamento de transtorno de estresse agudo ou transtorno de estresse pós-traumático, e, medicamento para a prevenção, alívio ou tratamento de sintoma de transtorno de estresse pós-traumático |
EP3868375A4 (en) | 2018-10-19 | 2022-06-29 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy |
US10611737B1 (en) | 2019-10-24 | 2020-04-07 | Sk Biopharmaceuticals Co., Ltd. | Method for preparing aryl 2-tetrazol-2-yl ketone with improved selectivity |
CN118221604A (zh) * | 2019-10-24 | 2024-06-21 | 爱思开生物制药株式会社 | 具有改进的选择性的制备芳基2-四唑-2-基酮的方法 |
EP4062906A4 (en) | 2019-11-22 | 2024-01-03 | SK Biopharmaceuticals Co., Ltd. | ORAL PHARMACEUTICAL COMPOSITION COMPRISING A CARBAMATE COMPOUND AND METHOD FOR PREPARING THIS COMPOSITION |
CN111705096A (zh) * | 2020-06-29 | 2020-09-25 | 上海舒泽生物科技研究所 | 一种酶转化法生产β-烟酰胺单核苷酸的方法 |
AU2021321092A1 (en) | 2020-08-06 | 2023-03-09 | Sk Biopharmaceuticals Co., Ltd. | Solid oral composition comprising carbamate compound, and preparation method therefor |
ES2931000B2 (es) * | 2022-07-14 | 2023-07-07 | Univ Madrid Complutense | Proceso para la preparación de cenobamato |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61134339A (ja) | 1984-12-05 | 1986-06-21 | Seitetsu Kagaku Co Ltd | α−ジケトンの立体特異的還元による光学活性アルコ−ルならびにその製造方法 |
JPH054943A (ja) | 1990-08-30 | 1993-01-14 | Sagami Chem Res Center | 光学活性β,δ−ジケト酸エステル及びその還元体 |
EP0538693A3 (en) | 1991-10-23 | 1994-08-17 | Squibb & Sons Inc | Stereoselective preparation of halophenyl alcohols |
DK0630402T3 (da) | 1992-03-13 | 1997-12-22 | Forschungszentrum Juelich Gmbh | Ny ketoesterreduktase, fremstilling deraf og anvendelse deraf til enzymatiske redoxreaktioner |
WO1994007888A1 (en) | 1992-09-25 | 1994-04-14 | Chiroscience Limited | Chiral compounds and their use |
CA2103932A1 (en) | 1992-11-05 | 1994-05-06 | Ramesh N. Patel | Stereoselective reduction of ketones |
JPH0759592A (ja) | 1993-08-25 | 1995-03-07 | Osaka City | 光学活性ジオールの製造方法 |
JP3574682B2 (ja) | 1993-09-24 | 2004-10-06 | ダイセル化学工業株式会社 | 新規な酵素、該酵素を製造する方法、該酵素をコードするdna、該dnaを含む形質転換体、該酵素による光学活性アルコール等の製造方法 |
PL177372B1 (pl) | 1995-03-30 | 1999-11-30 | Akad Rolnicza | Sposób otrzymywaniaoptycznie czynnych alkoholi aromatycznych |
DE19610984A1 (de) | 1996-03-21 | 1997-09-25 | Boehringer Mannheim Gmbh | Alkohol-Dehydrogenase und deren Verwendung zur enzymatischen Herstellung chiraler Hydroxyverbindungen |
JPH1094399A (ja) | 1996-09-24 | 1998-04-14 | Fukui Pref Gov Sangyo Shinko Zaidan | 酵素を用いる光学活性アルコールの製造法 |
US6218156B1 (en) | 1997-02-07 | 2001-04-17 | Kaneka Corporation | Gene encoding carbonyl reductase, and methods for its use |
DE19707008A1 (de) | 1997-02-21 | 1998-08-27 | Basf Ag | Verfahren zur Herstellung von enantiomerenreinen Alkoholen |
JPH10248591A (ja) | 1997-03-06 | 1998-09-22 | Sumitomo Chem Co Ltd | 光学活性アルコールの製造方法 |
JPH10287634A (ja) | 1997-04-11 | 1998-10-27 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体 |
JPH11130761A (ja) | 1997-10-24 | 1999-05-18 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾール誘導体 |
JP2000236883A (ja) | 1998-12-21 | 2000-09-05 | Daicel Chem Ind Ltd | 新規なカルボニル還元酵素、該酵素の製造方法、該酵素をコードするdnaおよびこれを利用したアルコールの製造方法 |
EP1153919A4 (en) * | 1999-02-16 | 2002-10-02 | Kaneka Corp | SUBSTITUTED ACETYLPYRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR OPTICALLY ACTIVE BETA3 ADRENERGIC RECEPTOR AGONIST USING THE SAME |
EP1152054B1 (en) | 1999-12-03 | 2005-03-23 | Kaneka Corporation | Novel carbonyl reductase, gene thereof and method of using the same |
DE10037101A1 (de) | 2000-07-27 | 2002-02-07 | Degussa | Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz |
HUP0400261A3 (en) | 2001-03-22 | 2005-11-28 | Bristol Myers Squibb Co | Stereoselective reduction of substituted acetophenone |
DE10119274A1 (de) | 2001-04-20 | 2002-10-31 | Juelich Enzyme Products Gmbh | Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen |
JP4630486B2 (ja) | 2001-05-28 | 2011-02-09 | ダイセル化学工業株式会社 | 新規な(r)−2,3−ブタンジオール脱水素酵素、その製造方法、及びこれを利用した光学活性アルコールの製造方法 |
JP2003230398A (ja) | 2001-12-07 | 2003-08-19 | Daicel Chem Ind Ltd | 光学活性アルコールの製造方法 |
CA2479705C (en) | 2002-03-19 | 2011-02-01 | Mitsubishi Chemical Corporation | Novel carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same |
JP2003289895A (ja) | 2002-04-03 | 2003-10-14 | Sumitomo Chem Co Ltd | メチレンジオキシフェニル基を有するケトン化合物の不斉還元による光学活性アルコール化合物の製造方法 |
EP1505155B1 (en) | 2002-04-30 | 2008-12-03 | Kaneka Corporation | Carbonyl reductase, gene thereof and use of the same |
US7056540B2 (en) | 2002-10-29 | 2006-06-06 | Council Of Scientific And Industrial Research | Enzymatic process for the preparation of optically active alcohols from ketones using tuberous root Daucus carota |
JP4366097B2 (ja) | 2003-02-28 | 2009-11-18 | 住友化学株式会社 | 還元酵素遺伝子及びその利用 |
JP4295531B2 (ja) | 2003-03-10 | 2009-07-15 | 三菱化学株式会社 | 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法 |
DE10315760A1 (de) * | 2003-04-07 | 2004-10-21 | Basf Ag | L-Carnitin Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von substituierten (S)-Alkanolen |
JP2004313033A (ja) | 2003-04-14 | 2004-11-11 | Daiichi Fine Chemical Co Ltd | 新規なカルボニル還元酵素及びそれをコードする遺伝子並びにその用途 |
JP4213524B2 (ja) | 2003-04-17 | 2009-01-21 | ダイセル化学工業株式会社 | 新規なカルボニル還元酵素、その酵素をコードするdnaを含むポリヌクレオチド、その製造方法、およびこれを利用した光学活性アルコールの製造方法 |
JP4294382B2 (ja) | 2003-06-06 | 2009-07-08 | ダイセル化学工業株式会社 | (2s,3s)−2,3−ブタンジオール脱水素酵素 |
DE10327454A1 (de) | 2003-06-18 | 2005-01-20 | Juelich Enzyme Products Gmbh | Oxidoreduktase aus Pichia capsulata |
JP4205496B2 (ja) | 2003-06-19 | 2009-01-07 | 三菱化学株式会社 | 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法 |
DE102004037669A1 (de) | 2003-08-13 | 2005-03-10 | Juelich Enzyme Products Gmbh | (R)- und (S)-1,4-Dichlor-butan-2-ol und Verfahren zu deren Herstellung durch enantioselektive enzymatische Reduktion von 1,4-Dichlor-butan-2-on |
KR20060108640A (ko) | 2003-10-31 | 2006-10-18 | 다이이치 파인 케미칼 가부시키가이샤 | 신규한 플라스미드 및 이의 용도 |
DE10354779A1 (de) | 2003-11-21 | 2005-06-23 | Juelich Enzyme Products Gmbh | Oxidoreduktase aus Metschnikowia zobellii |
KR20070013269A (ko) | 2004-02-04 | 2007-01-30 | 가부시키가이샤 에이피아이 코포레이션 | 광학활성을 가지는 알콜 또는 카본산의 제조방법 |
JP2005218348A (ja) | 2004-02-05 | 2005-08-18 | Daicel Chem Ind Ltd | 光学活性α−ヒドロキシアミドの製造方法 |
DE102004022686A1 (de) | 2004-05-05 | 2005-11-24 | Basf Ag | Verfahren zur Herstellung optisch aktiver Alkohole |
AT413541B (de) | 2004-05-10 | 2006-03-15 | Iep Gmbh | Verfahren zur herstellung von 2-butanol |
JP2007274901A (ja) | 2004-05-12 | 2007-10-25 | Taisho Pharmaceut Co Ltd | 光学活性プロパルギルアルコールの製造方法 |
DE102004029112B4 (de) | 2004-06-11 | 2007-06-21 | Julich Chiral Solutions Gmbh | Alkoholdehydrogenase zur stereoselektiven Gewinnung von Hydroxyverbindungen |
JP4757804B2 (ja) | 2004-10-27 | 2011-08-24 | 株式会社カネカ | 新規カルボニル還元酵素、その遺伝子、およびその利用法 |
AT501928B1 (de) | 2004-10-27 | 2010-09-15 | Iep Gmbh | Verfahren zur herstellung von chiralen alkoholen |
DE102004059376A1 (de) | 2004-12-09 | 2006-06-22 | Consortium für elektrochemische Industrie GmbH | GDH-Mutante mit verbesserter chemischer Stabilität |
US20060177913A1 (en) | 2005-02-08 | 2006-08-10 | Consortium Fur Elektrochemische Industrie Gmbh | Process for enantioselective enzymatic reduction of keto compounds |
AT501496B1 (de) | 2005-02-21 | 2007-03-15 | Iep Gmbh | Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen |
JP4966189B2 (ja) | 2005-02-25 | 2012-07-04 | 株式会社カネカ | 光学活性2級アルコールの製造方法 |
DE102005010804A1 (de) | 2005-03-07 | 2006-09-14 | Basf Ag | Verfahren zur Herstellung optisch aktiver Alkohole |
US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
US7393667B2 (en) | 2005-05-31 | 2008-07-01 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
AT502395B1 (de) | 2005-07-27 | 2007-03-15 | Iep Gmbh | Oxidoreduktasen zur stereoselektiven reduktion von ketoverbindungen |
JP4745762B2 (ja) | 2005-09-02 | 2011-08-10 | 住友化学株式会社 | 還元酵素及びその利用 |
DE102005044736A1 (de) | 2005-09-19 | 2007-03-22 | Basf Ag | Neue Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von optisch aktiven Alkanolen |
AT502185B1 (de) | 2005-09-23 | 2007-02-15 | Iep Gmbh | Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen |
AT503017B1 (de) | 2005-12-19 | 2007-07-15 | Iep Gmbh | Verfahren zur enantioselektiven enzymatischen reduktion von hydroxyketoverbindungen |
WO2007099764A1 (ja) | 2006-02-28 | 2007-09-07 | Kaneka Corporation | 新規カルボニル還元酵素、その遺伝子、およびそれらを利用した光学活性アルコールの製造方法 |
WO2007099994A1 (ja) | 2006-03-02 | 2007-09-07 | Kaneka Corporation | 新規カルボニル還元酵素、その遺伝子、ベクター、形質転換体、およびそれらを利用した光学活性アルコールの製造方法 |
DE102006010994A1 (de) | 2006-03-09 | 2007-09-13 | Wacker Chemie Ag | Verfahren zur enzymatischen Herstellung von chiralen Alkoholen |
US8304216B2 (en) | 2006-03-31 | 2012-11-06 | Kaneka Corporation | Method for production of erythro-or threo-2-amino-3-hydroxypropionic acid ester, novel carbonyl reductase, gene for the reductase, vector, transformant, and method for production of optically active alcohol using those |
KR20090033864A (ko) | 2006-06-05 | 2009-04-06 | 다이셀 가가꾸 고교 가부시끼가이샤 | 광학 활성 알코올의 제조방법 |
JP4903512B2 (ja) | 2006-07-13 | 2012-03-28 | 住友化学株式会社 | 還元酵素遺伝子を含む発現ベクター |
WO2008035187A2 (en) | 2006-09-21 | 2008-03-27 | Dow Global Technologies Inc. | Alcohol dehydrogenase from agromyces sp. and a method of producing a chiral secondary alcohol using same |
DE102006055047A1 (de) | 2006-11-22 | 2008-05-29 | Wacker Chemie Ag | Verfahren zur Herstellung von Dihydroxy-Verbindungen aus Diketo-Verbindungen durch enzymkatalysierte enantioselektive Reduktion |
DE102006056526A1 (de) | 2006-11-30 | 2008-06-05 | Archimica Gmbh | Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung |
AT504542B1 (de) | 2006-12-07 | 2008-09-15 | Iep Gmbh | Verfahren zur enantioselektiven enzymatischen reduktion von secodionderivaten |
ATE535608T1 (de) | 2007-06-20 | 2011-12-15 | Basf Se | Verfahren zur herstellung optisch aktiver alkohole unter verwendung einer dehydrogenase aus azoarcus sp. ebn1 |
TWI601825B (zh) * | 2007-09-27 | 2017-10-11 | Iep有限公司 | 對映異構選擇性酶催化還原中間產物之方法 |
DE102007052112A1 (de) | 2007-10-30 | 2009-05-07 | Chiracon Gmbh | Pflanzliche Biokatalysatoren zur Herstellung optisch aktiver Hydroxyverbindungen |
WO2009070822A2 (en) | 2007-12-05 | 2009-06-11 | Angewandte Biokatalyse Kompetenzzentrum Gmbh | Recombinant pichia pastoris cell |
CN101314787A (zh) | 2008-06-24 | 2008-12-03 | 江苏华荣生物科技有限公司 | 用红酵母还原酶制剂制备光学活性手性仲醇的方法 |
CN101319236A (zh) | 2008-07-01 | 2008-12-10 | 江南大学 | 水/离子液体两相体系中生物催化不对称还原羰基化合物的方法 |
CN101358183B (zh) | 2008-09-03 | 2010-07-14 | 华东理工大学 | 红豆羰基还原酶、制备方法和用途 |
EP2445890B1 (en) * | 2009-06-22 | 2015-05-06 | SK Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
-
2010
- 2010-10-14 US US12/904,267 patent/US8404461B2/en active Active
- 2010-10-15 MX MX2012004055A patent/MX2012004055A/es active IP Right Grant
- 2010-10-15 KR KR1020127008386A patent/KR101708437B1/ko active IP Right Grant
- 2010-10-15 CA CA2776743A patent/CA2776743C/en active Active
- 2010-10-15 EP EP10823619.1A patent/EP2488505B1/en active Active
- 2010-10-15 JP JP2012534114A patent/JP5797656B2/ja active Active
- 2010-10-15 PL PL10823619T patent/PL2488505T3/pl unknown
- 2010-10-15 WO PCT/KR2010/007069 patent/WO2011046380A2/en active Application Filing
- 2010-10-15 AU AU2010307466A patent/AU2010307466B2/en active Active
- 2010-10-15 ES ES10823619.1T patent/ES2536488T3/es active Active
- 2010-10-15 RU RU2012119801/04A patent/RU2539983C2/ru active
- 2010-10-15 BR BR112012008858-0A patent/BR112012008858B1/pt not_active IP Right Cessation
- 2010-10-15 HU HUE10823619A patent/HUE025816T2/en unknown
- 2010-10-15 MY MYPI2012001325A patent/MY162997A/en unknown
- 2010-10-15 CN CN201080046299.4A patent/CN102574821B/zh active Active
-
2012
- 2012-03-22 IL IL218787A patent/IL218787A0/en active IP Right Grant
- 2012-04-12 ZA ZA2012/02629A patent/ZA201202629B/en unknown
- 2012-04-13 CL CL2012000959A patent/CL2012000959A1/es unknown
- 2012-12-28 HK HK12113548.6A patent/HK1172625A1/xx unknown
-
2013
- 2013-02-26 US US13/776,964 patent/US9068207B2/en active Active
-
2015
- 2015-05-22 US US14/719,728 patent/US9434970B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012004055A (es) | Metodo para la preparacion de ester (r) -1-aril-2-tetrazolil-etili co de acido carbamico. | |
MX2011013982A (es) | Metodo para la preparacion de este ( r ) - 1 - aril - 2 - tetrazolil - etilico de acido carbomico. | |
WO2011127409A3 (en) | Methods and compositions related to fatty alcohol biosynthetic enzymes | |
WO2010122578A3 (en) | Process for preparation of sitagliptin and its intermediates | |
EP2336347A4 (en) | L-amino acid-producing microorganism and method for producing L-amino acid | |
WO2010093262A8 (en) | Alcohol production process | |
WO2011140520A3 (en) | Bioreactors comprising fungal strains | |
WO2012057486A3 (ko) | 화장용 바이오셀룰로오스 마스크팩 시트 및 이의 제조방법 | |
WO2009049274A8 (en) | Microorganism engineered to produce isopropanol | |
BRPI0917169A2 (pt) | método para a produção de álcool concentrado a partir de caldo de fermentação | |
WO2010039626A3 (en) | Methods to communicate a timestamp to a storage system | |
WO2010045629A3 (en) | Production of c5-c8 alcohols using evolved enzymes and metabolically engineered microorganisms | |
WO2012129548A3 (en) | In situ expression of lipase for enzymatic production of alcohol esters during fermentation | |
EP2468400A4 (en) | Catalyst and alcohol synthesis method | |
IL192333A0 (en) | Photobioreactor, system and method for the cultivation of microalgae | |
ZA201001052B (en) | Process for the enantioselective enzymatic reduction of intermediates | |
WO2014052920A3 (en) | Methods of producing acetoin and 2,3-butanediol using photosynthetic microorganisms | |
PT1851322E (pt) | Processo para a redução enzimática enantiosselectiva de compostos cetónicos | |
WO2012142302A3 (en) | Biocatalytic process for preparing eslicarbazepine and analogs thereof | |
WO2012099934A3 (en) | Butanol production by microorganisms having nadh coupling | |
EP2543723A4 (en) | PROCESS FOR THE PREPARATION OF GLUCOSIDASE AND ENZYME COMPOSITIONS AND BIOMASS HYDROLYSIS PROCESSES | |
AU2011235718A1 (en) | Method of manufacturing zeaxanthin by fermentation | |
WO2011145867A3 (ko) | 알킬락테이트의 제조방법 및 이를 이용한 락타미드의 제조방법 | |
EP2211625A4 (en) | MUSHROOMS AND A METHOD FOR MAKING AN INSECTICIDE OF THESE STEELS | |
GB201020026D0 (en) | New process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |